CT ENTERPRISE (03839) appoints Kobboon Srichai as a non-executive director.

date
18:09 24/02/2026
avatar
GMT Eight
Charoen Pokphand Group International (03839) announced that, effective February 24, 2026, Mr. Xie Jiren, the chairman of the company, has been transferred from a non-executive director to an executive director of the company, as he will be assuming executive duties within the group; Mr. Li Shaozhu has resigned as an executive director and CEO (industrial business) of the company due to his desire to devote more time to other personal matters, and he will also no longer serve as a member of the board's remuneration committee; Ms. Kobboon Srichai has been appointed as a non-executive director of the company; Mr. Ma Deshou, the current executive director of the company, has been appointed as the CEO and a member of the remuneration committee of the company; following Mr. Ma Deshou's appointment, Mr. Li Shaoqing will no longer serve as the CEO (biochemical business) of the company, but will remain as an executive director.
CT ENTERPRISE (03839) announced that Mr. Xie Jiren, the Chairman of the company, has been reappointed as the Executive Director of the company from February 24, 2026, due to his new executive role within the group. Mr. Li Shaozhu has resigned as the Executive Director and Chief Executive Officer (Industrial Business) of the company in order to focus on personal matters, and he is no longer a member of the Board Remuneration Committee. Ms. Kobboon Srichai has been appointed as a Non-Executive Director of the company. Mr. Ma Deshou, the current Executive Director of the company, has been appointed as the Chief Executive Officer and a member of the Remuneration Committee. Following Mr. Ma Deshou's appointment, Mr. Li Shaoqing will no longer serve as the Chief Executive Officer (Biochemical Business) of the company, but will remain as an Executive Director.